A Randomised, Double-blind, Placebo-controlled, Three-way Cross-over Single Center Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
A randomised, double-blind, placebo-controlled, three-way cross-over single center study to
characterize the phenotype in patients with Morton's Neuroma and to explore the effect of
local administration of Xylocaine (lidocaine)
Interventional
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
The baseline phenotypic Quantitative sensory testing (QST) variables (e.g. heat, cold, touch and mechanical pain perception). Sensory tests will be performed to measure pain and skin sensitivity by use of different pressure (mN) and temperature ( C)
Before and after drug injection at Day 1
No
Bror Jonzon, MD, PhD
Study Director
AstraZeneca R&D Södertälje, Sweden
Sweden: Medical Products Agency
D2285M00032
NCT01298310
February 2011
May 2012
Name | Location |
---|